Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Arthritis Research & Therapy|December 2, 2016
Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registryLeslie R Harrold, George W Reed, Daniel H Solomon, et al.Arthritis Care & Research|May 7, 2020
Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid ArthritisJeffrey R Curtis, J Lynn Palmer, George W Reed, et al.Rheumatology (Oxford, England)|March 25, 2017
Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registryArthur Kavanaugh, Edward Keystone, Jeffrey D Greenberg, et al.Annals of Internal Medicine|March 17, 2004
Health plan members' views about disclosure of medical errorsKathleen M Mazor, Steven R Simon, Robert A Yood, et al.The American Journal of Managed Care|February 9, 2005
Health plan members' views on forgiving medical errorsKathleen M Mazor, Steven R Simon, Robert A Yood, et al.The Journal of Rheumatology|May 3, 2015
Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA RegistryLeslie R Harrold, George W Reed, Ashwini Shewade, et al.Annals of the Rheumatic Diseases|December 4, 2013
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factorLeslie R Harrold, George W Reed, Joel M Kremer, et al.Arthritis Research & Therapy|February 4, 2014
Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one yearJonathan Kay, Olga Morgacheva, Susan P Messing, et al.American Journal of Epidemiology|July 2, 2003
Association between eating patterns and obesity in a free-living US adult populationYunsheng Ma, Elizabeth R Bertone, Edward J Stanek, et al.Rheumatology and Therapy|October 18, 2016
Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona RegistryDimitrios A Pappas, Ani John, Jeffrey R Curtis, et al.Pageof 7